You are here
November 14-15, 2018
Discovery and Validation of Biomarkers to Develop Non-Addictive Therapeutics for Pain
Marriott Wardman-Park, Washington, DC
Description: This workshop will inform the community about current regulatory standards and guidelines for the development of biomarkers and endpoints for pain, evaluate the state of the science in pain biomarker development, and explore potential scientific and collaborative approaches that could facilitate the discovery and validation of robust biomarkers and endpoints that would provide the tools necessary for the diagnosis and treatment of pain conditions.
January 30-31, 2019
A Critical Evaluation of Animal Pain Models Workshop
Bethesda North Marriott Hotel and Conference Center, Rockville, Maryland
Description: This meeting will convene experts in the field of animal models for pain and experts in translational development of pain therapeutics to discuss screening programs in the preclinical process for determining if a compound should be developed to treat pain in the clinical setting.
June 18, 2018
HEALing Communities Study Design Workshop
March 5-6, 2018
Contributions of Social and Behavioral Research in Addressing the Opioid Crisis
- Meeting Agenda
- Participant List
- Executive Summary
- Full Summary
- Videocast (Day 1)
- Videocast (Day 2)
December 12-13, 2017
FNIH Planning Meeting: Partnership to Address the Opioid Crisis
Discussion: Expand options for the treatment of opioid use disorder, overdose prevention/reversal, and pain through a public-private partnership.
The meeting agenda and executive summary are available on the FNIH program webpage.
December 11, 2017
Using Science to Inform Practice and Policy: A Coordinated Approach to Research Priority Setting
July 7, 2017
Understanding the Neurobiological Mechanisms of Pain
Discussion: Enhance our understanding of the complex neurobiological mechanisms of pain and accelerate the development of novel pain treatments.
June 16, 2017
Development of Safe, Effective, Non-Addictive Pain Treatments
Discussion: Expedite the screening and development of promising agents to treat chronic pain with little or no potential for misuse or addiction.
June 5, 2017
Medications Development for Opioid Use Disorders and for Overdose Prevention and Reversal
Discussion: Stimulate innovative directions in preventing and treating opioid use disorders and overdoses.
This page last reviewed on November 5, 2018